BBR Partners LLC continued to hold its position in Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 100,050 shares of the insurance provider’s stock at the close of the second quarter. Humana accounts for approximately 5.1% of BBR Partners LLC’s holdings, making the stock its 4th largest holding. BBR Partners LLC owned 0.07% of Humana worth $24,074,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in HUM. Federated Investors Inc. PA lifted its holdings in shares of Humana by 608.1% during the 2nd quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock worth $8,331,000 after acquiring an additional 29,736 shares during the period. Teachers Advisors LLC lifted its holdings in shares of Humana by 31.6% during the 2nd quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock worth $151,792,000 after acquiring an additional 151,603 shares during the period. Cipher Capital LP lifted its holdings in shares of Humana by 7.7% during the 2nd quarter. Cipher Capital LP now owns 9,734 shares of the insurance provider’s stock worth $2,342,000 after acquiring an additional 698 shares during the period. Creative Planning lifted its holdings in shares of Humana by 0.3% during the 2nd quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock worth $1,173,000 after acquiring an additional 15 shares during the period. Finally, OZ Management LP lifted its holdings in shares of Humana by 4.9% during the 2nd quarter. OZ Management LP now owns 667,478 shares of the insurance provider’s stock worth $160,608,000 after acquiring an additional 30,927 shares during the period. Institutional investors own 95.12% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Humana Inc. (HUM) Position Held by BBR Partners LLC” was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/humana-inc-hum-position-held-by-bbr-partners-llc/1580538.html.

In other Humana news, insider William Kevin Fleming sold 3,071 shares of Humana stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the transaction, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Brian P. Leclaire sold 4,971 shares of Humana stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the transaction, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 60,566 shares of company stock worth $15,326,746. Company insiders own 0.80% of the company’s stock.

HUM has been the topic of several recent analyst reports. Citigroup Inc. initiated coverage on shares of Humana in a report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price objective on the stock. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. BidaskClub lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $257.00 price objective on the stock in a report on Thursday, May 25th. Finally, Argus upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price objective on the stock in a report on Friday, June 9th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Humana presently has an average rating of “Buy” and a consensus target price of $246.60.

Shares of Humana Inc. (NYSE:HUM) traded down 1.3383% during mid-day trading on Friday, reaching $235.4462. 210,559 shares of the company’s stock traded hands. The company has a market capitalization of $34.03 billion, a P/E ratio of 19.3687 and a beta of 0.87. The firm has a 50-day moving average price of $250.95 and a 200-day moving average price of $232.23. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $259.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the previous year, the business posted $2.30 EPS. On average, equities research analysts forecast that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Tuesday, August 29th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.